Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Zosano Pharma Corp (ZSAN)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Mar-31-22 | Dec-31-21 | Sep-30-21 | Mar-31-21 | Dec-31-20 | Sep-30-20 | Jun-30-20 | Jun-05-20 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 8-K |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | | | 100.0% |
| Cost of goods sold | 65.2% | 105.7% | 134.9% | 62.8% | 76.3% | | | 156.1% |
| Gross profit | 34.8% | -5.7% | -34.9% | 37.2% | 23.7% | | | -56.1% |
| Research and development | 3394.7% | 5355.2% | 2375.0% | 2065.9% | 2389.3% | | | |
| General and administrative | 2228.8% | 2589.7% | 1000.8% | 1090.7% | 1177.2% | | | 56.1% |
| Depreciation | 416.7% | 492.0% | 158.7% | 168.6% | 193.3% | | | |
| EBIT | -5588.6% | -7950.6% | -3410.7% | -3119.4% | -3542.9% | | | -156.1% |
| Pre-tax income | -25309.8% | -8012.6% | -3439.7% | -3155.8% | -3615.2% | | | -160.1% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | | | 0.0% |
| Net income | -25309.8% | -8012.6% | -3439.7% | -3155.8% | -3615.2% | | | -160.1% |
|